- Home
- NYC vs NXPL Comparison
NYC vs NXPL Comparison
Compare NYC & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYC
- NXPL
- Stock Information
- Founded
- NYC 2013
- NXPL 1997
- Country
- NYC United States
- NXPL United States
- Employees
- NYC N/A
- NXPL N/A
- Industry
- NYC Real Estate
- NXPL Telecommunications Equipment
- Sector
- NYC Finance
- NXPL Telecommunications
- Exchange
- NYC Nasdaq
- NXPL Nasdaq
- Market Cap
- NYC 23.5M
- NXPL 21.9M
- IPO Year
- NYC N/A
- NXPL N/A
- Fundamental
- Price
- NYC $9.49
- NXPL $1.18
- Analyst Decision
- NYC
- NXPL
- Analyst Count
- NYC 0
- NXPL 0
- Target Price
- NYC N/A
- NXPL N/A
- AVG Volume (30 Days)
- NYC 3.8K
- NXPL 45.8K
- Earning Date
- NYC 11-07-2024
- NXPL 11-12-2024
- Dividend Yield
- NYC N/A
- NXPL N/A
- EPS Growth
- NYC N/A
- NXPL N/A
- EPS
- NYC N/A
- NXPL N/A
- Revenue
- NYC $62,629,000.00
- NXPL $66,404,000.00
- Revenue This Year
- NYC N/A
- NXPL N/A
- Revenue Next Year
- NYC $3.18
- NXPL N/A
- P/E Ratio
- NYC N/A
- NXPL N/A
- Revenue Growth
- NYC N/A
- NXPL 498.52
- 52 Week Low
- NYC $5.46
- NXPL $0.99
- 52 Week High
- NYC $10.91
- NXPL $2.68
- Technical
- Relative Strength Index (RSI)
- NYC 57.58
- NXPL 42.90
- Support Level
- NYC $8.66
- NXPL $1.35
- Resistance Level
- NYC $9.10
- NXPL $1.37
- Average True Range (ATR)
- NYC 0.49
- NXPL 0.11
- MACD
- NYC 0.02
- NXPL -0.01
- Stochastic Oscillator
- NYC 77.74
- NXPL 26.32
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.
About NXPL NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.